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ABSTRACT 
 
RADIOPROTECTIVE EFFECTS OF GINSENG EXTRACT IN GAMMA-
RAYS INDUCED CHROMOSOMAL DAMAGES OF HUMAN LYMPHOCYTE. 
Ginsan, a polysaccharide extracted from Panax ginseng and subsequently referred as ginseng, 
posses various biological properties as an anticancer and antioxidant agent. Ginseng also 
approved effective against radiation effects through its immunomodulating actions in whole 
body irradiated mouse. But its protective effects on radiation induced DNA damage are not 
thoroughly investigated, mainly in human. This experiment aimed to assess the effects of 
ginseng at 2 working doses in suppressing radiation effects of human peripheral blood 
lymphocyte (PBL) i.e. chromosome aberration and micronuclei yields. The treatment times 
were 24 hours before, subsequently (0 hour) or 3 hours after and irradiation with gamma rays 
at doses of 0.5 - 2.0 Gy (dose rate of 3.16 Gy/min). Treated and untreated blood cultivation 
and metaphase spreading technique was done according to standard procedures. Results 
showed that without ginseng treatments, radiation significantly increased dicentrics and 
micronuclei frequencies. Different with the results in mouse study, however, our results 
indicated that none of the experimental concentrations of ginseng crude water extract tested 
had an effect on baseline chromosomal aberration and micronuclei (MN) yields in PBL.                 
A protective effect was only seen in chromosome aberration yields of sample irradiated with 
2.0 Gy and treated with ginseng 3 h post irradiation rather than 24 h pre-irradiation in one 
volunteer. Opposite results that ginseng suspected to be a weak radiosensitizer was found in 
some cases. This may be due to discrepancies exist in route of treatment and its fundamental 
mechanisms of protective action between both studies. Even though in general it was not 
effective, the possible mechanism involved in radioprotective influence of ginseng                            
is discussed. 
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INTRODUCTION 
 
Ginseng that has been used as a medicine for at least 2,000 years, 
currently is being cultivated throughout the world [1]. Numerous biochemical 
and pharmacological studies reveal that ginseng possess various biological 
properties as an anticancer, antioxidant, anti-inflammatory, antibiotic,               
anti-fungal and anti-hepatotoxic agent. Anticancer and therapeutics were 
potent of its active components such as ginsenosides in saponins of the 
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ginseng root, while polysaccharides have been observed to                               
have immunomodulating and antiproliferative effects in certain tumor                
cell lines [2-6].  
In more detail studies ginseng was known to increase the rate of 
production of serum albumin and gamma globulin as well as DNA and RNA 
protein, and lipid synthesis in bone marrow cells. In radiation therapy 
adjunct, several studies reported that water-extracted polysaccharides of 
ginseng injection into mice with 100 mg/kg before exposure to ionizing 
radiation could survived at given radiation dose 45% more intense than 
control. This is due to cytokines that are required for hematopoietic recovery 
was induced with enhanced T-helper 1 function. Moreover, the pretreated 
cells had a significantly increased number of bone marrow, spleen cells, 
granulocyte-macrophage colony-forming cells, and circulating neutrophils 
[4,7]. The antioxidant activities of ginseng also help explain its                     
DNA-preserving qualities with respect to some carcinogens and 
inflammation. Ginseng extracts have been shown to scavenge reactive 
oxidative species, a typical product induced by ionizing radiation [8-10].  
Zhang et al [11] have revealed that the water-soluble extract of whole 
ginseng injected intraperitoneally 24 h before irradiated gave the best 
protection against gamma radiation in mice in term of LD50/30. Treatment 
with ginseng for 24h before radiation exposure, resulted in a significant linear 
decline of MN yields as ginseng concentration increases. These results 
indicated that ginseng crude water extract exerts no apparent cytogenetic 
effect on human PBL at concentrations up to 2000 microgram/ML as 
evaluated by the CBMN assay and the protection of ginseng water extract 
against 137Cs-induced MN in human PBL is concentration-dependence. 
Therefore, their findings indicated that ginseng may have therapeutic value as 
a possible radioprotector for normal tissue during radiotherapy of cancer 
patients. Preliminary clinical observations suggest that following 
radiotherapy or chemotherapy, partially purified ginseng components may 
reduce therapeutic-related side effects and stimulate recovery of 
hematopoietic functions in cancer patients. It is well known that the G0 stage 
PBL are particularly suitable for quantifying the effects of radioprotective 
chemicals in modifying radiation response, however, information regarding 
the effect of ginseng on human PBL is still need to be elucidated [6].  
Ionizing radiations induced chromosomal aberrations such as 
dicentrics, rings, translocations, etc. appear as a result of double strand breaks 
and misrepaired damage [12]. The analysis of dicentric in lymphocytes is 
considered the most-sensitive biological method to quantify exposure to 
radiation for doses >0.1 Gy, if an adequate number of metaphases are 
analysed [13]. Damage to chromosomes is also manifested as breaks and 
fragments, which appears as MN in the rapidly proliferating cells [14]. 
Micronuclei are produced during mitosis due to various mechanisms, i.e., 
acentric fragments, multicentric chromosomes, damaged kinetochores and 
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spindle fiber defects and it can be detected in the cytoplasm besides the cell 
nucleus as small nucleus-like particles [15]. In additional, the formation of 
MN in cytokinesis-blocked PBL is one of the most sensitive biomarkers for 
assessing genotoxicity or radiation damage in situ [16,17]. The aim of the 
present study is to evaluate the possible properties of ginseng extract against 
radiation-induced chromosomal damage. 
 
EXPERIMENTAL METHODS 
 
Plant Materials and Treatment Procedure 
 
In this experiment, ginseng was obtained from Laboratory of Radiation 
Immunology, KIRAMS, Seoul, Korea. As reported, ginseng                               
(a polysaccharide) preparation was started by purification from the ethanol 
insoluble fraction of the aqueous Panax ginseng extract, as described 
previously [19,20]. Ginseng was dissolved in phosphate buffer saline               
(PBS, pH 7.4) and filtered through a 0.25 micrometer Millipore membrane 
(Millipore, USA). The concentration of ginseng used were 100 and                   
1000 µg/ML working doses. 
 
Blood Collection and Irradiation 
 
Peripheral blood samples were collected in sterile heparinised 
vacutainers (Becton Dickinson) from three healthy volunteers (all males) 
aged between 30 and 47 years old (mean 39.67 y). No medicines or drugs 
were taken by all volunteers for at least six months prior to sampling and free 
from any diseases for more than 12 months. The treatment time in this 
experiment was similar with others [11,18,19] i.e. 24 hour before, 
immediately and 3 hours after irradiation. For 24 h treatment, blood was 
mixed with culture medium in conical tube and keep in incubator at 37oC for 
24 hours. Two other blood samples from the same volunteer were irradiated 
with ionizing radiation doses and then mixed with culture medium, followed 
by treatment with ginseng immediately and 3 hours post exposure. All three 
treatments were irradiated at a dose rate of 3.16 Gy/min in Gammacell 3000 
Elam Nordion International machine located in KIRAMS. The doses of 
gamma rays irradiation were 0.5-2.0 Gy. 
 
Culture Set up For Unstable Chromosomal Aberration 
  
The procedure of analysis was according to standard procedures given 
by IAEA [21] with slight modifications. Two milliliters of irradiated and 
ginseng treated and control bloods were cultured at 37oC for 48 h in a 
humidified atmosphere containing 5% CO2. The culture medium consisted of 
8.0 ML of RPMI-1640 supplemented with 10% heat inactivated feotal calf 
serum and 1% streptomycin/penicillin. All the components of the culture 
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medium were obtained from Gibco. Besides this, 3.0% ML of 
phytohemagglutinin (PHA-Gibco BRL, Grand Island, NY) was added to 
stimulate cell division. After cultured for 48 hours, the contents of the tube 
were then centrifuged for ten minutes at 1500 rpm and re-suspend in 8 ML of 
75 mM KCl (pre-warmed to 37oC) for twenty minutes. At this stage, 2 ML of  
-20oC fresh fixative solution (3:1 = methanol : acetic acid glacial) was added 
into the tube, and this fixation step was repeated four times (until white 
sediment was obtained). 
 
Scoring the Metaphases and Imaging 
 
Two slides were prepared for each sample, encoded, stained with 10% 
Giemsa (Merck) and mounted. The number of aberrations was observed 
under an Nikon microscope, using the 100x oil immersion objective, and a 
cell was considered as aberrant if it had one or more unstable CA (dicentric, 
rings and chromosome fragments) in complete metaphases with                          
46 centromers or more only as per the scoring criteria described in IAEA 
[21]. At least 500 first division metaphase cells were scored per sample. In the 
control samples 1000-2000 metaphase cells were analysed per donor. 
Tricentrics and tetracentrics were considered as one and two dicentric 
equivalents, respectively. Light microscopy was coupled to an image analysis 
system using a CCD (Char Coupled Device) camera (Model DP70, Olympus) 
to facilitate scoring and imaging. Digitized data were stored into a personal 
computer and processed using Adobe Photoshop. 
 
Culture Set up For Micronucleus Assay 
 
One and half milliliter of whole blood of the same volunteers was put 
into cultures containing 8.5 ML of RPMI 1640 medium with L-glutamine and 
25 mM HEPES buffer (Gibco Laboratories) supplemented with 10% fetal calf 
serum (Gibco) and antibiotics. Purified phytohaemagglutinin (PHA P,                
30 µg/ML; Sigma Chemical Co., St Louis, MO) was added as mitogen. 
Cytochalasin B (6 µg/ML, stock solution 2 mg/ML in dimethylsulphoxide; 
Sigma Chemical Co.) was added 43 h after culture initiation to block 
cytokinesis. After an incubation period of 72 h the cells were collected, 
treated with a hypotonic solution of 0.075 M KCl (cooled at 4oC) and 
prefixed with 2 ML of cold pre-fixative solution (3% formaldehyde in fresh 
fixative solution). Fixative was done with a mixture of methanol/glacial 
acetic acid as described [21,22]. After fixation the cells were dropped onto 
clean slides and allowed to dry. After mounted, MN was scored according           
to IAEA [21]. 
 
Scoring Micronuclei (MN) 
 
Scoring of MN was conducted under a Nikon microscope with 100x 
magnification. The MN frequencies were scored according to the criteria 
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proposed by IAEA [21] and Fenech, M. [23] : the diameter of an MN is less 
than one third of the diameter of the macronucleus, it is non-refractile and is 
not linked to the macronucleus by a nucleoplasmic bridge. MN partly 
overlapping with the nucleus or with each other were also taken into account. 
One thousand binucleated (BN) cells were scored on one or two slides per 
individual. Imaging was done as chromosomal aberration. 
 
RESULTS AND DISCUSSION 
 
The frequencies of chromosomal aberrations (dicentrics and rings) for 
different doses of gamma irradiation in control and ginseng treated cultured 
human blood lymphocytes (24 h before-, immediately after- and 3 h               
after-irradiation) were presented in Table 1. Whereas the results of 
experiment for micronuclei yield in the same lymphocyte cells were 
presented in Table 2. An increase in the frequencies of dicentrics and rings 
were observed in a dose dependent manner. Maximum number of dicentric 
(as high as 362 in 1000 cells counted) was observed at highest dose (2.0 Gy). 
Results showed that without ginseng treatments, radiation significantly 
increased dicentrics and micronuclei frequencies. Different with the results 
in mouse study, however, our results indicated that none of the experimental 
concentrations of ginseng crude water extract tested had an effect on 
baseline chromosomal aberration yields in PBL. A protective effect was only 
seen in chromosome aberration yields of sample irradiated with 2.0 Gy and 
treated with ginseng 3 h post irradiation rather than 24 h pre-irradiation. 
Opposite results showed that ginseng tended to be a radiosensitizer was 
found in some cases. This may be due to discrepancies exist in route of 
treatment and its fundamental mechanisms of protective action between  
both studies. 
All concentration of ginseng assessed (100 and 1000 µg/ml) was not 
clearly decreased the dicentric frequencies when the lymphocytes were 
exposed to 1 Gy, moreover to 2.0 Gy. At 2.0 Gy irradiation, 100 µg/ML of 
ginseng did not brought the dicentric frequencies still in normal level     
(Figure 1). Only 100 µg/ML of ginseng brought down the dicentric 
frequency to near normal level when the lymphocytes were irradiated at 
2.0 Gy irradiation and this only found in one sample. Even 1000 µg/ML of 
ginseng pretreatment exhibited no any decreased levels of chromosome 
aberration in gamma-irradiated lymphocytes for all doses of irradiation. 
Ginseng pretreated (100 µg/ML) lymphocytes (24 h pre-treated) showed 
slightly decreased frequencies of dicentric+rings when compared with                    
gamma-irradiated cells only. Our very simple study also shows that              
gamma-irradiation caused a significant decrease in the levels of CA when 
compared with the normal lymphocytes. Ginseng pretreated groups did not 
showed any differences in dicentric yields when compared                             
with corresponding gamma-irradiative groups. Further, ginseng pretreatment              
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did not decreased frequencies of these radiation induced                    
chromosomal alterations.  
 
 
 
Figure 1. Three dicentric chromosomes induced by gamma rays with dose of 
2.0 Gy and ginseng treatment 24 h before irradiation. 
 
Table 1. Frequencies of chromosome aberrations induced by exposure to 
0.1-2.0 Gy of gamma rays in blood sample treated with ginseng              
24 pre-, 0 h post- and 3 h post-irradiation. 
 
Volunteer 
no. 
(sex, age) 
Time of 
ginseng 
treatment 
Ginseng 
Dose 
(µg/ML) 
Radiation 
dose (Gy) 
Total cells 
counted 
No. cell with 
dicentric & 
rings 
Frequency of 
dicentric & rings 
1 
M, 42 y 
- 
0 h post 
- 
0 h post 
- 
0 h post 
- 
0 h post 
0 
100 
0 
100 
0 
100 
0 
100 
0.0 
0.0 
0.1 
0.1 
0.5 
0.5 
1.0 
1.0 
800 
500 
650 
500 
800 
500 
500 
500 
1 
3 
12 
11 
48 
38 
74 
65 
0.0013 
0.0040 
0.0185 
0.0220 
0.0600 
0.0760 
0.1480 
0.1300 
2 
M, 30 y 
24 h pre 
24 h pre 
24 h pre 
3 h post 
3 h post 
3 h post 
100 
100 
100 
100 
100 
100 
0.0 
0.5 
1.0 
0.0 
0.5 
1.0 
800 
500 
500 
800 
500 
500 
3 
27 
79 
2 
26 
74 
0.0038 
0.0540 
0.1580 
0.0025 
0.0520 
0.1480 
3  
M, 42 y 
- 
- 
- 
24 h pre 
24 h pre 
24 h pre 
3 h post 
3 h post 
3 h post 
0 
0 
0 
100 
100 
100 
100 
100 
100 
0.0 
1.0 
2.0 
0.0 
1.0 
2.0 
0.0 
1.0 
2.0 
2000 
2000 
1500 
800 
500 
500 
800 
500 
500 
2 
114 
362 
3 
116 
246 
1 
70 
202 
0.0010 
0.0570 
0.2413 
0.0038 
0.2320 
0.4920 
0.0013 
0.1400 
0.4040 
4 
M, 47 y 
0 h post 
0 h post 
0 h post 
0 h post 
0 h post 
0 h post 
0 h post 
0 h post 
0 h post 
0 
100 
1000 
0 
100 
1000 
0 
100 
1000 
0.0 
0.0 
0.0 
0.5 
0.5 
0.5 
1.0 
1.0 
1.0 
500 
400 
400 
500 
400 
400 
500 
400 
400 
1 
1 
2 
10 
7 
8 
15 
19 
12 
0.0020 
0.0025 
0.0050 
0.0200 
0.0175 
0.0200 
0.0300 
0.0470 
0.0300 
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Across the 1.0 - 2.0 Gy in vitro radiation dose range used in this study, 
the yields of MN in PBL without ginseng treatment were consistently higher 
for higher doses of radiation. We found that a 24 h pre-treated ginseng crude 
water extract appeared to have very weak radioprotective effects as 
evidenced by MN analysis (Table 2). However, in general the addition of 
ginseng at the concentrations used in this study could not clearly decreased 
the 137Cs-induced MN in PBL. 
 
Table 2. Effects of ginseng treatment on MN yields in human irradiated and 
non-irradiated peripheral blood lymphocytes. 
 
Volunteer 
no. 
(sex, age) 
Time of 
ginseng 
treatment 
Ginseng 
Dose 
(µg/ML) 
Radiation 
dose (Gy) 
Total cells 
counted 
Total no. of 
MN 
Frequency 
(MN/cell 
counted) 
1 
M, 47 y 
0 h post 
0 h post 
0 h post 
0 h post 
0 h post 
0 h post 
0 h post 
0 h post 
0 h post 
0 
100 
1000 
0 
100 
1000 
0 
100 
1000 
0.0 
0.0 
0.0 
0.5 
0.5 
0.5 
1.0 
1.0 
1.0 
1000 
1000 
1000 
1000 
1000 
1000 
1000 
1000 
NA 
3 
11 
11 
35 
39 
71 
107 
113 
NA 
0.003 
0.011 
0.011 
0.035 
0.039 
0.071 
0.107 
0.113 
NA 
2  
M, 42 y 
0 h post 
0 h post 
0 h post 
0 h post 
0 h post 
0 h post 
0 
100 
0 
100 
0 
100 
0.0 
0.0 
0.5 
0.5 
1.0 
1.0 
1000 
1000 
1000 
1000 
1000 
1000 
13 
16 
53 
51 
111 
103 
0.013 
0.016 
0.053 
0.051 
0.111 
0.103 
3 
M, 30 y 
3 h post 
3 h post 
3 h post 
24 h pre 
24 h pre 
24 h pre 
1000 
1000 
1000 
1000 
1000 
1000 
0.0 
0.5 
1.0 
0.0 
0.5 
1.0 
1000 
1000 
1000 
1000 
1000 
1000 
12 
52 
97 
14 
66 
98 
0.012 
0.052 
0.097 
0.014 
0.066 
0.098 
4  
M, 42 y 
3 h post 
3 h post 
3 h post 
24 h pre 
24 h pre 
24 h pre 
1000 
1000 
1000 
1000 
1000 
1000 
0.0 
1.0 
2.0 
0.0 
1.0 
2.0 
1000 
1000 
1000 
1000 
1000 
1000 
17 
90 
200 
10 
111 
228 
0.017 
0.090 
0.200 
0.010 
0.111 
0.228 
 
Different with study on mice, this study could not revealed a 
radioprotective effect of ginseng. In assessing the effect of ginseng extract in 
modifying the radiation-induced MN yield in human Go PBL with 
cytokinesis-blocked (CB) assay, we found that at 0 Gy and without the 
presence of ginseng extract, MN yield was 11.9 per 1000 binucleated (BN) 
cells (Figure 2). Different concentrations of ginseng crude water extract 
treatment did not affect the MN yields. After 0.5 and 1.0 Gy exposures, 
radiation alone increased the MN yields, respectively, to 44.0 and 109.0 per 
1000 BN cells. However, treatment with ginseng for 24 h before, 
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immediately after or 3 hour after radiation exposure, resulted in no reduction 
in MN yields for all ginseng concentrations tested. 
 
 
 
Figure 2. Micronuclei (small round shape besides binucleated cells in 
cytoplasm) induced by 0.5 Gy of gamma rays and treated with 
ginseng of 100 µg/ML 3 hour post irradiation. 
 
These results indicated that ginseng crude water extract exerts no 
apparent cytogenetic effect on human PBL at all concentrations assessed as 
evaluated by the CBMN assay; and the protection of ginseng water extract 
against 137Cs-induced MN in human PBL is not known. Therefore, our 
findings could not clearly indicate that ginseng may have therapeutic value as 
a possible radioprotector for normal tissue during radiotherapy of cancer 
patients. Based on the limited quantitative information in the literature, this 
simple research addresses the issue of the radioprotective effects of ginseng 
on mammalian cells obtained from three human peripheral blood 
lymphocytes. The significant radioprotective effects of different ginseng 
preparations were not demonstrated in vitro by cytokinesis-blocked 
micronuclei assay. Results of research did not clearly indicate that the           
water-soluble extract of whole ginseng appears to give a protection against 
radiation - induced damage. However, although the exact underlying 
radioptrotective mechanism of ginseng is unclear, it could be through its 
antioxidantative capability by scavenging free radicals responsible for                 
DNA damage. 
The role of plant extracts in ionizing radiation injury and its potential 
to reduce deleterious effects had been studied in animal models and human 
for more than 50 years [24]. Ginseng, one of more than ten thousands plant 
extracts analyzed its efficacy, are proven to be less effective radioprotectors 
in human in certain doses, as approved in this study, but may provide a 
longer window of protection against lethality and other effects of low dose, 
low-dose rate exposures. As many ginseng extracts had antimutagenic 
properties, it is need further examination with respect to long-term radiation 
(chronics) effects. In vivo studies in experimental animals have included 
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protection against radiation-induced lethality due to hematopoietic or 
gastrointestinal injury, other specific tissue damage, apoptosis, mutagenesis, 
and carcinogenesis. 
 Since the 1980’s, the radioprotective effects of Panax ginseng                          
(P. ginseng) and its partially purified constituents have been documented in 
experimental models [3,18]. Ben-Hur and Fulder [3] demonstrated that in the 
presence of partially purified P. ginseng saponin mixture, Chinese hamster 
V79 fibroblasts are significantly more resistant to subsequent -irradiation as 
determined by the ex vivo colony forming assay. In the studies of cultured 
spleen lymphocytes from mice, application of P. ginseng water extract 48 h 
before -ray-irradiation has been shown to reduce the frequency of DNA 
double strand breaks, and it also has been demonstrated to reduce the degree 
of radiation-induced apoptosis in both jejunal crypt cells and hair follicles 
[25]. In addition, Hsu et al. [26] found in ICR mice that the intraperitoneal 
injection of a Chinese herbal medicine that contains 25% of P. ginseng root 
before whole-body X-ray exposure (0–5 Gy) markedly enhanced the 
radiotolerance of bone marrow stem cells and peripheral hematocytes.  
In contrast to the research in rodents, however, reports on the 
radioprotective effects of ginseng in human populations are very limited, 
although one clinical study from Korea suggests that partially purified                
P. ginseng components may reduce morbidities and stimulate the recovery of 
hematopoietic functions in cancer patients [27]. Moreover, since unrepaired 
or misrepaired DNA damage in PBL may be responsible for micronuclei 
(MN) formation, Lee et al [18] recently assessed the effect of P. ginseng 
dried root crude water extract on the radiation-induced MN formation in 
human G0 PBL ex vivo using the cytokinesis-blocked micronuclei assay and 
found that treatment with ginseng 24 h before 137Cs exposure (2 Gy) resulted 
in a linear decline of MN yields as ginseng concentration increased). These 
findings suggest that the ginseng crude water extract may contain a potential 
radioprotective constituent with therapeutic value in dampening the damaging 
effects of ionizing radiation on normal tissues without exhibiting any negative 
effects on PBL. Obviously, experimental studies on the radioprotective 
potential of this important ginseng compound are critically needed. 
Song et al [19] reported that ginseng polysaccharide isolated from 
ginseng had a mitogenic activity and was also found to significantly increase 
the number of bone marrow cells, spleen cells, granulocyte-macrophage 
colony-forming cells, and circulating neutrophils, lymphocytes and platelets 
in irradiated mice. Pretreatment with ginseng protected mice from the lethal 
effects of ionizing radiation more effectively than when it was given 
immediately after or at various times after irradiation. A significant increase 
in the LD50/30 of mice pretreated with ginseng was also observed. These 
findings indicate that ginseng may be a useful agent to reduce the time 
necessary for reconstituting hematopoietic cells after irradiation. 
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It has long been known that ionizing radiation can interact directly 
with biological chromophores such as deoxyribonucleic acid (DNA) and in 
so doing, can damage those molecules. The use of ionizing radiation has 
become an integral part of modern medicine. It is used for diagnostic as well 
as therapeutic purposes. The therapeutic differentiation may be achieved with 
chemical radiation sensitizers or protectors. The development of radiation 
protectors is important not only to enhance the effectiveness of cancer 
treatment, but also for the study of the underlying mechanisms of radiation 
cytotoxicity [27]. A wide variety of compounds have been tested for 
radioprotective activity, including ginseng extract and many antioxidants 
[28,29]. Of all the compounds studied as potential radioprotective agents, 
unfortunately, available radioprotective substances possess unacceptable 
toxicity limiting its clinical usefulness and the precise mechanisms 
responsible for radiation-induced cell death remain uncertain. Therefore,                 
it is necessary to develop protectors that will minimize toxicity while 
maintaining efficacy [30]. This was assessed in this very simple and 
preliminary experiment.  
In our study, we found that ginseng did not renders protection against 
gamma-radiation induced DNA damage expressed as chromosomal 
aberration and micronuclei in human lymphocyte. This is different with 
recent studies which are demonstrate that ginseng exhibits protective activity 
against oxygen species in whole body irradiated mouse. The baseline of 
protecting action of plant extract is discussed in the following paragraphs.            
It seems that the strong free radical scavenging effects of P. ginseng have 
been extensively documented by many studies [8, 31, 32] where the 
radioprotective effect of P. ginseng has been closely linked to its 
antioxidative capability through both the chelating of transition metal ions 
and the scavenging of free radicals responsible for DNA damage [33]. Lipid 
peroxidation leads to altered lysosomal membrane permeability and results in 
the release of hydrolytic enzymes in response to radiation-induced damage  
in vivo: P. ginseng extract has been shown to inhibit lipid peroxidation 
through transition metal chelation and scavenging of hydroxyl and 
superoxide radicals [31]. Recently, most effects of ginseng have been 
attributed to its antioxidant action. Moreover, ginseng has been shown to be 
strongly radioprotective through its ability to stimulate hematopoietic stem 
cells (colony-forming unit spleen) and produce a battery of cytokines such 
IL-1, IL-6, IL-12 and TNF-α. Its was also to be proven in study with mice 
that ginseng exerted its radioprotective effect through activation of 
antioxidant defense systems [4,25]. However, this was not seen in PBL cells 
irradiated in vitro with gamma rays as revealed by this study. 
A large number of compounds natural and synthetic have been 
evaluated for the purpose of radioprotection [34]. The development of 
radiation protectors is important not only to enhance the effectiveness of 
cancer treatment, but also for the study of the underlying mechanisms of 
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radiation cytotoxicity [35]. Hence search for an ideal radioprotector without 
side effects like hypotension, nausea, vomiting etc. and toxicity is a 
compelling urgency. These side effects limit its clinical usefulness. An ideal 
radioprotector also should be free from side effects, should be long acting, 
less expensive and capable of long term storage without change in action and 
constitution. Moreover, the most effective in vivo radioprotectors, however, 
like plant flavanoids and thiol compounds studied so far are effective when 
administered before irradiation, as they must be present in the system at the 
time of irradiation [35]. Hence they can be used only when the eventuality of 
the exposure is known and are not suitable against unplanned exposures, e.g. 
accidents, spillage, warfare and terrorist attack. Free radical scavenging may 
be a likely mechanism of action as the extract was found to possess 
significant hydroxyl radical scavenging activity. 
This research focused on the effectivity of ginseng to attenuate the 
radiation effects expressed as chromosomal damages. Ginseng is typical 
Korean and Chinese plant and also cultivated in USA. In fact, Indonesia also 
has many types of plant such as Buah Merah, of which their extracts can be 
used as radioprotector. Buah merah or Red fruit (pandanous conoideus), an 
original traditional medicine of Papua Indonesia, was approved for healing 
for any degenerative diseases, such as cancer, tumor, hepatitis, lever disease, 
prostate, diabetes, gout, cholesterol, hypertension, stroke, and can be used for 
a healing of HIV [36,37]. Buah merah contains high concentration of active 
and important compounds such as beta-caroten, tocopherol, oleic acid, 
linoleic acid, and dekanoic. The research should be undertaken to check the 
in vivo and in vitro radioprotective property of the aqueous extract of              
Buah merah which remain unexplored for their effectiveness in suppressing 
radiation damages especially chromosomal aberration/instability either by 
using rodent as experimental animal or pheripheral blood of Indonesian 
people. Further investigations are necessary to identify the active 
component(s) responsible for protection and to study their mechanism of 
action. This plant is widely available in our country, it is worthwhile to 
conduct detailed studies in order to explore the full potential of this plant in 
human radiation protection. Other plants, temulawak or wild ginger          
(curcuma xanthorrhiza Roxb) and Brotowali (Tiospora rumpii boerl) is also 
has prospective availability for cancer treatment, hence for suppressing 
chromosomal instability. 
 
CONCLUSION 
 
Results of this simple experiment showed that without ginseng 
treatments, gamma radiation significantly increased dicentrics and 
micronuclei frequencies. None of the experimental concentrations of ginseng 
crude water extract tested had an effect on baseline chromosomal aberration 
and micronuclei yields in pheripheral blood lymphocytes. A protective effect 
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was only seen in chromosome aberration yields of sample irradiated with            
2.0 Gy and treated with ginseng 3 h post irradiation rather than 24 h                    
pre-irradiation. Opposite results that ginseng suspected to be a radiosensitizer 
was found in some cases. This may be due to discrepancies exist in route of 
treatment and its fundamental mechanisms of protective action between both 
studies. Most effects of ginseng have been attributed to its antioxidant action 
and strongly radioprotective through its ability to stimulate hematopoietic 
stem cells. 
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